Skip to main content

Advertisement

Peer Review reports

From: Impact of a switch to fingolimod versus staying on glatiramer acetate or beta interferons on patient- and physician-reported outcomes in relapsing multiple sclerosis: post hoc analyses of the EPOC trial

Original Submission
17 Jul 2014 Submitted Original manuscript
22 Aug 2014 Reviewed Reviewer Report - Tereza Gabelic
23 Aug 2014 Reviewed Reviewer Report - Tomas Uher
6 Oct 2014 Author responded Author comments - Luigi Barbato
Resubmission - Version 2
6 Oct 2014 Submitted Manuscript version 2
28 Oct 2014 Author responded Author comments - Luigi Barbato
Resubmission - Version 3
28 Oct 2014 Submitted Manuscript version 3
Publishing
6 Nov 2014 Editorially accepted
26 Nov 2014 Article published 10.1186/s12883-014-0220-1

You can find further information about peer review here.

Back to article page